HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An inhibitory role of progerin in the gene induction network of adipocyte differentiation from iPS cells.

Abstract
Lipodystrophies, characterized by partial or complete loss of adipose tissue, have been associated with mutations in the lamin A gene. It remains unclear how lamin A mutants interfere with adipose tissue formation. Hutchinson-Gilford progeria syndrome (HGPS) presents the most severe form of lamin A-associated diseases, whose patients show a complete loss of subcutaneous fat. Using iPSCs reprogrammed from HGPS fibroblasts, we induced adipocyte formation from iPSC derived embryoid bodies or from iPSC derived mesenchymal stem cells. Both approaches revealed a severe lipid storage defect in HGPS cells at late differentiation stage, faithfully recapitulating HGPS patient phenotype. Expression analysis further indicated that progerin inhibited the transcription activation of PPARγ2 and C/EBPα, but had little effects on the early adipogenic regulators. Our experiments demonstrate two comparable approaches of in vitro modeling lipodystrophies with patient-specific iPSCs, and support a regulatory role of lamin A in the terminal differentiation stage of adipogenesis.
AuthorsZheng-Mei Xiong, Christina LaDana, Di Wu, Kan Cao
JournalAging (Aging (Albany NY)) Vol. 5 Issue 4 Pg. 288-303 (Apr 2013) ISSN: 1945-4589 [Electronic] United States
PMID23596277 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Lamin Type A
  • Nuclear Proteins
  • Protein Precursors
  • prelamin A
Topics
  • Adipocytes (cytology)
  • Animals
  • Cell Differentiation (physiology)
  • Cells, Cultured
  • Gene Expression Regulation (physiology)
  • Lamin Type A
  • Nuclear Proteins (genetics, metabolism)
  • Pluripotent Stem Cells (metabolism)
  • Protein Precursors (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: